Showing 1 - 8 of 8
This paper examines how equitable, differentiated pricing can improve access to and affordability of medicines, particularly in low- and middle-income countries, and how governments and supranational agencies can create an environment that enables pharmaceutical companies to operate a...
Persistent link: https://www.econbiz.de/10010856414
During the past 20 years, the world pharmaceutical industry has experienced a dramatic increase in R&D intensity. We apply and extend a model developed by Grabowski and Vernon (2000) with a pooled data sample of the 15 publicly listed Japanese drug firms for the period 1987 to 1998. As in the...
Persistent link: https://www.econbiz.de/10010856449
This paper investigates the influence of human resource management on learning from internal and external sources of knowledge. Learning for innovation is a key ingredient of catching-up processes. The analysis builds on survey data about pharmaceutical firms in Mexico. Results show that the...
Persistent link: https://www.econbiz.de/10010712046
The life sciences sector (and biotechnology in particular) has emerged as a prospective area, and attracted a lot of attention recently. Multinational companies in the life sciences seek to explore new markets, and, on the other side, governments strive to develop the life sciences sector...
Persistent link: https://www.econbiz.de/10010712051
Interactive learning, particularly between firms and public research organizations (PRO), nurtures the dynamics of systems of innovation. Limited interaction contributes to explain poor performance in R&D and ultimately, in innovation by developing countries. But why this is so? Based on...
Persistent link: https://www.econbiz.de/10010712332
As tariffs fall over time, attention inevitably focuses on non-tariff measures (NTMs). Governments are increasingly imposing mandatory technical regulations on products for reasons of security, health or the environment and have facilitated the introduction of non-mandatory (voluntary) standards...
Persistent link: https://www.econbiz.de/10010712394
to patent protection on pharmaceuticals that can affect health care and delivery in developing countries. The potential …
Persistent link: https://www.econbiz.de/10010712396
An obstacle to the widespread adoption of environmentally friendly energy technologies such as stationary and mobile fuel cells is their high upfront costs. While much lower prices seem to be attainable in the future due to learning curve cost reductions that increase rapidly with the scale of...
Persistent link: https://www.econbiz.de/10010856442